Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma

Bedoya, DM; Dutoit, V; Migliorini, D

Migliorini, D (corresponding author), Univ Geneva, Ctr Translat Res Oncohematol, Geneva, Switzerland.; Migliorini, D (corresponding author), Swiss Canc Ctr Leman, Lausanne, Switzerland.; Migliorini, D (corresponding author), Univ Geneva, Fac Med, Brain Tumor & Immune Cell Engn Grp, Geneva, Switzerland.; Migliorini, D (corresponding author), Geneva Univ Hosp HUG, Dept Oncol, Geneva, Switzerland.

FRONTIERS IN IMMUNOLOGY, 2021; 12 ():

Abstract

Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Outstanding r......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索